Device Trial Radar · NCT04247581
ECG App Algorithms Clinical Validation Study
Last checked: Nov 20, 2026Latest source record: Sep 28, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
546
Actual
Start
Jan 7, 2020
Primary completion
Mar 20, 2020
Study completion Mar 20, 2020
Sponsor
- Lead sponsor
- Apple Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- IQVIA Pty Ltd
- First posted
- Jan 30, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the performance of ECG classification algorithms and their ability to classify heart rhythms into multiple categories of rhythms and heart rates
Conditions
- Atrial Fibrillation
Interventions
1-lead ECGDevice
1 lead ECG - All participants will record three single-lead ECGs at rest and three single-lead ECGs after exercise. Intervention Other: Exercise - All participants will undergo three trials of exercise. Other interventions: 12-lead ECG - All participants will simultaneously record 12-lead ECGs during rest and exercise sessions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Trials With Correct Classification of Normal Sinus Rhythm on Simultaneous 12-lead ECG as "Sinus Rhythm" or "High Heart Rate" on a Readable and Classifiable ECG App Strip.Time frame: 1 Day
- Percentage of Trials With Correct Classification of AF on Simultaneous 12-lead ECG as "AF" on a Readable and Classifiable ECG App Strip.Time frame: 1 Day
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Hope Research Institute
Phoenix, Arizona
Clinical Research of South Florida
Coral Gables, Florida
American Health Network of Indiana LLC
Avon, Indiana
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.